drugset / Trial / NCT01838772
HCV Treatment in HIV Co-Infected Patients in Asia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the effectiveness and tolerability of hepatitis C virus (HCV) treatment in HIV co-infected patients in routine health care services in Asia through a pilot model of care for treatment of HCV in resource-limited settings.
Timeline
- Start
- 2013-12
- Primary completion
- 2016-06
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2a | Protein / enzyme biologic | 1.5 ug/kg | Subcutaneous |
| Subject | Ribavirin | Small molecule | — | — |